Roger Jeffs - 10 Jun 2026 Form 4 Insider Report for Axsome Therapeutics, Inc. (AXSM)

Reporting relationship: Director
Issuer ticker: AXSM
Reported as of: 10 Jun 2026
Net transaction value: -$141,656
SEC form: 4
Accepted by SEC: 11 Jun 2026, 20:34:11 UTC
Prior SEC filing: 10 Jun 2026
Next SEC filing: 14 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Nick Pizzie, Attorney-in-Fact

Key filing fact

Roger Jeffs filed Form 4 for Axsome Therapeutics, Inc. (AXSM) on 11 Jun 2026.

Key facts

This page summarizes Roger Jeffs's Form 4 filing for Axsome Therapeutics, Inc. (AXSM).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 11 Jun 2026, 20:34.

Change

Previous filing in this sequence was filed on 10 Jun 2026.
Current net transaction value: -$141,656.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001231615 Primary reporting owner

JEFFS ROGER

Relationship: Director
Address: C/O AXSOME THERAPEUTICS, INC., ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK
Signature: /s/ Nick Pizzie, Attorney-in-Fact
Signature date: 11 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AXSM transaction

Common Stock

Sale

Transaction value: $70,407
Shares: -286
Change %: -0.49%
Price: $246.18
Shares after: 58,653
Date: 10 Jun 2026
Ownership: Direct
Footnotes: F1, F2

AXSM transaction

Common Stock

Sale

Transaction value: $71,248
Shares: -286
Change %: -0.49%
Price: $249.12
Shares after: 58,367
Date: 11 Jun 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 2 footnotes

Footnote F1

Such transaction was pursuant to a pre-approved 10b5-1 plan, which has now been completed.

Footnote F2

These shares were sold to cover taxes associated with the settlement of RSUs that were initially granted to the Reporting Person on June 6, 2025.